IDH3A and glioblastoma: Confounded patient selection may mean that the study samples are not representative of the intended population (“glioblastomas, isocitrate dehydrogenase (IDH)-wild type” and “astrocytoma, IDH-mutant, grade 4”) which limits the generalizability of the results to the clinic.